SCHEDULE: Vanguard Reports Zero Beneficial Ownership in HealthEquity

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in HealthEquity Inc. following an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 9 to Schedule 13G for HealthEquity Inc. Common Stock.
• The filing reports 0% beneficial ownership of HealthEquity Inc. Common Stock by The Vanguard Group.
• This change is a direct result of an internal realignment at The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538 (January 12, 1998).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The event date requiring this statement's filing was March 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for HealthEquity Inc. as it primarily reflects a change in The Vanguard Group's internal reporting structure rather than a change in investment thesis or a divestment from the company by Vanguard's underlying funds.

Positives

• The filing clarifies The Vanguard Group's reporting structure, indicating a more granular disclosure approach by its subsidiaries, which can enhance transparency regarding specific fund holdings.

Negatives

• The Vanguard Group, as the parent entity, no longer reports beneficial ownership in HealthEquity Inc., which might be misinterpreted by some investors as a complete divestment if the context of the internal realignment is overlooked.

Risks

• There is a potential for misinterpretation by investors regarding The Vanguard Group's overall exposure to HealthEquity Inc. due to the shift to disaggregated reporting, potentially leading to unwarranted market reactions.

Future Outlook

The filing does not provide forward-looking statements or guidance for HealthEquity Inc. It focuses solely on The Vanguard Group's beneficial ownership reporting change due to an internal realignment.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment."
• "Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538 (January 12, 1998)."
• "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that this filing reflects a strategic decision by The Vanguard Group to disaggregate its beneficial ownership reporting. This move aligns with broader trends among large institutional investors to enhance transparency and clarify reporting responsibilities across complex organizational structures, particularly in response to regulatory guidance like SEC Release No. 34-39538. It does not necessarily indicate a change in the underlying investment strategy or total holdings by Vanguard's broader family of funds, but rather a change in how those holdings are reported by the parent entity.

Stakeholder Impact

• Shareholders of HealthEquity Inc. may initially perceive a reduction in institutional ownership, but understanding the context of Vanguard's internal realignment clarifies that underlying holdings by Vanguard's subsidiaries may still exist.
• The Vanguard Group's internal stakeholders are impacted by the realignment, requiring adjustments to internal processes and compliance for how different business divisions report their holdings.

Key Dates

Recommendation

The filing primarily details a change in The Vanguard Group's internal reporting structure, not a fundamental shift in investment strategy regarding HealthEquity Inc. While the parent entity now reports 0% beneficial ownership, this is due to disaggregated reporting by its subsidiaries. Investors should not interpret this as a divestment by Vanguard's funds, but rather a change in how ownership is disclosed. Therefore, a 'hold' recommendation is appropriate as the core investment thesis for HealthEquity Inc. remains unaffected by this administrative change.

Keywords

HealthEquity Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Ownership, Internal Realignment